Fol. Biol. 2012, 58, 166-172

https://doi.org/10.14712/fb2012058040166

Resveratrol Inhibits Proliferation of Primary Rat Hepatocytes in G0/G1 by Inhibiting DNA Synthesis

Juan A. Rubiolo1,2, H. López-Alonso1, V. Martín-Vázquez1, N. M. Fol-Rodríguez2, M. R. Vieytes2, L. M. Botana1, F. V. Vega2

1Departamento de Farmacología, Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, Spain
2Departamento de Fisiología, Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, Spain

References

1. Ahmad, N., Adhami, V. M., Afaq, F., Feyes, D. K., Mukhtar, H. (2001) Resveratrol causes WAF-1/p21-mediated G(1)phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7, 1466-1473.
2. Alfert, M., Geschwind, I. L. (1958) The development of polysomaty in rat liver. Exp. Cell Res. 15, 230-232. <https://doi.org/10.1016/0014-4827(58)90079-X>
3. Berry, M., Friend, d. (1969) High-yield preparation of isolated rat liver parenchymal cells. J. Cell. Biol. 43, 506-520. <https://doi.org/10.1083/jcb.43.3.506>
4. Bertelli, A., Bertelli, A. A., Gozzini, A., Giovannini, L. (1998) Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 24, 133-138.
5. Bertelli, A. A., Giovannini, L., Stradi, R., Bertelli, A., Tillement, J. P. (1996) Plasma, urine and tissue levels of transand cis-resveratrol (3,4’,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React. 18, 67-71.
6. Bohm, N., Noltemeyer, N. (1981) development of binuclearity and DNA-polyploidization in the growing mouse liver. Histochemistry. 72, 55-61. <https://doi.org/10.1007/BF00496779>
7. Brodsky, W. Y., Uryvaeva, I. V. (1977) Cell polyploidy: its relation to tissue growth and function. Int. Rev. Cytol. 50, 275-332. <https://doi.org/10.1016/S0074-7696(08)60100-X>
8. Bronstad, G. O., Sand, T. E., Christoffersen, T. (1983) Bidirectional concentration-dependent effects of glucagon and dibutyryl cyclic AMP on DNA synthesis in cultured adult rat hepatocytes. Biochim. Biophys. Acta 763, 58-63. <https://doi.org/10.1016/0167-4889(83)90025-3>
9. Delmas, D., Passilly-Degrace, P., Jannin, B., Cherkaoui Malki, M., Latruffe, N. (2002) Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int. J. Mol. Med. 10, 193-199.
10. Dong, Z. (2003) Molecular mechanism of the chemopreventive effect of resveratrol. Mutat. Res. 523-524, 145-150. <https://doi.org/10.1016/S0027-5107(02)00330-5>
11. Eckl, P. M. (1993) Occurrence and possible consequences of multipolar mitoses in primary cultures of adult rat hepatocytes. J. Cell. Physiol. 154, 601-607. <https://doi.org/10.1002/jcp.1041540319>
12. El-Mowafy, A. M., Alkhalaf, M. (2003) Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24, 869-873. <https://doi.org/10.1093/carcin/bgg015>
13. Epstein, C. J. (1967) Cell size, nuclear content, and the development of polyploidy in the mammalian liver. Proc. Natl. Acad. Sci. USA 57, 327-334. <https://doi.org/10.1073/pnas.57.2.327>
14. Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., Aggarwal, B. B. (2003) Resveratrol blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 102, 987-995. <https://doi.org/10.1182/blood-2002-11-3550>
15. Fausto, N., Campbell, J. S. (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120, 117-130. <https://doi.org/10.1016/S0925-4773(02)00338-6>
16. Fremont, L. (2000) Biological effects of resveratrol. Life Sci. 66, 663-673. <https://doi.org/10.1016/S0024-3205(99)00410-5>
17. Gautam, S. C., Xu, Y. X., Dumaguin, M., Janakiraman, N., Chapman, R. A. (2000) Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 25, 639-645. <https://doi.org/10.1038/sj.bmt.1702189>
18. Gosslau, A., Chen, M., Ho, C. T., Chen, K. Y. (2005) A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts. Br. J. Cancer 92, 513-521. <https://doi.org/10.1038/sj.bjc.6602300>
19. Gusman, J., Malonne, H., Atassi, G. (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22, 1111-1117. <https://doi.org/10.1093/carcin/22.8.1111>
20. Hsieh, T. C., Wu, J. M. (1999) Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell. Res. 249, 109-115. <https://doi.org/10.1006/excr.1999.4471>
21. Huang, C., Ma, W. Y., Goranson, A., Dong, Z. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20, 237-242. <https://doi.org/10.1093/carcin/20.2.237>
22. Ignatowicz, E., Baer-Dubowska, W. (2001) Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol. J. Pharmacol. 53, 557-569.
23. Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., El May, M., Gharbi, N., Kamoun, A., El-Fazaa, S. (2007) Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci. 80, 1033-1039. <https://doi.org/10.1016/j.lfs.2006.11.044>
24. Kuhnle, G., Spencer, J. P., Chowrimootoo, G., Schroeter, H., Debnam, E. S., Srai, S. K., Rice-Evans, C., Hahn, U. (2000) Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem. Biophys. Res. Commun. 272, 212-217. <https://doi.org/10.1006/bbrc.2000.2750>
25. Lancon, A., Delmas, D., Osman, H., Thenot, J. P., Jannin, B., Latruffe, N. (2004) Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem. Biophys. Res. Commun. 316, 1132-1137. <https://doi.org/10.1016/j.bbrc.2004.02.164>
26. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., Lin, J. K. (2003) Resveratrol-induced G2 arrest through the inhibition of CdK7 and p34CdC2 kinases in colon carcinoma HT29 cells. Biochem. Pharmacol. 65, 1053-1060. <https://doi.org/10.1016/S0006-2952(03)00011-X>
27. Liontas, A., Yeger, H. (2004) Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 24, 987-998.
28. Lu, J., Ho, C. H., Ghai, G., Chen, K. Y.(2001) Resveratrol analog, 3,4,5,4’-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counter-parts. Carcinogenesis 22, 321-328. <https://doi.org/10.1093/carcin/22.2.321>
29. Mgbonyebi, O. P., Russo, J., Russo, I. H. (1998) Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol. 12, 865-869.
30. Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., Kim, M. K., Beaven, M. A., Burgin, A. B., Manganiello, V., Chung, J. H. (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433. <https://doi.org/10.1016/j.cell.2012.01.017>
31. Ragione, F. D., Cucciolla, V., Borriello, A., Pietra, V. D., Racioppi, L., Soldati, G., Manna, C., Galletti, P., Zappia, V. (1998) Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun. 250, 53-58. <https://doi.org/10.1006/bbrc.1998.9263>
32. Refsnes, M., Thoresen, G. H., Sandnes, D., Dajani, O. F., Dajani, L., Christoffersen, T. (1992) Stimulatory and inhibitory effects of catecholamines on DNA synthesis in primary rat hepatocyte cultures: role of α1- and β-adrenergic mechanisms. J. Cell. Physiol. 151, 164-171. <https://doi.org/10.1002/jcp.1041510121>
33. Rubiolo, J. A., Mithieux, G., Vega, F. V. (2008) Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 591, 66-72. <https://doi.org/10.1016/j.ejphar.2008.06.067>
34. Rubiolo, J. A., Vega, F. V. (2008) Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species. Biomed. Pharmacother. 62, 606-612. <https://doi.org/10.1016/j.biopha.2008.06.034>
35. Sale, S., Verschoyle, R. D., Boocock, D., Jones, D. J., Wilsher, N., Ruparelia, K. C., Potter, G. A., Farmer, P. B., Steward, W. P., Gescher, A. J. (2004) Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4’-tetramethoxystilbene. Br. J. Cancer 90, 736-744. <https://doi.org/10.1038/sj.bjc.6601568>
36. Seglen, P. O. (1976) Preparation of isolated rat liver cells. Methods Cell. Biol. 13, 29-83. <https://doi.org/10.1016/S0091-679X(08)61797-5>
37. Severin, E., Willers, R., Bettecken, T. (1984) Flow cytometric analysis of mouse hepatocyte ploidy. II. The development of polyploidy pattern in four mice strains with different life spans. Cell Tissue Res. 238, 649-652. <https://doi.org/10.1007/BF00219884>
38. Signorelli, P., Ghidoni, R. (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16, 449-466. <https://doi.org/10.1016/j.jnutbio.2005.01.017>
39. Styles, J. A., Kelly, M., Pritchard, N. R., Elcombe, C. R. (1988) A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte. Carcinogenesis 9, 1647-1655. <https://doi.org/10.1093/carcin/9.9.1647>
40. Vintermyr, O. K., Mellgren, G., Boe, R., Doskeland, S. O. (1989) Cyclic adenosine monophosphate acts synergistically with dexamethasone to inhibit the entrance of cultured adult rat hepatocytes into S-phase: with a note on the use of nucleolar and extranucleolar [3H]-thymidine labelling patterns to determine rapid changes in the rate of onset of DNA replication. J. Cell. Physiol. 141, 371-382. <https://doi.org/10.1002/jcp.1041410219>
41. Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., Merillon, J. M. (2003) distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72, 2219-2233. <https://doi.org/10.1016/S0024-3205(03)00096-1>
42. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., Walle, U. K. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32, 1377-1382. <https://doi.org/10.1124/dmd.104.000885>
43. Walle, T., Walle, U. K., Sedmera, D., Klausner, M. (2006) Benzo[A]pyrene-induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue. Drug Metab. Dispos. 34, 346-350. <https://doi.org/10.1124/dmd.105.007948>
44. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., Forstermann, U. (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106, 1652-1658. <https://doi.org/10.1161/01.CIR.0000029925.18593.5C>
45. Wheatley, D. N. (1972) Binucleation in mammalian liver. Studies on the control of cytokinesis in vivo. Exp. Cell. Res. 74, 455-465. <https://doi.org/10.1016/0014-4827(72)90401-6>
46. Yu, C., Shin, Y. G., Chow, A., Li, Y., Kosmeder, J. W., Lee, Y. S., Hirschelman, W. H., Pezzuto, J. M., Mehta, R. G., van Breemen, R. B. (2002) Human, rat, and mouse metabolism of resveratrol. Pharm. Res. 19, 1907-1914. <https://doi.org/10.1023/A:1021414129280>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive